ZN-d5
ZN-d5-003
Phase 2 small_molecule completed
Quick answer
ZN-d5 for Amyloidosis is a Phase 2 program (small_molecule) at Zentalis Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Zentalis Pharmaceuticals
- Indication
- Amyloidosis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed